Latest Articles
- Do I always need a central venous catheter to administer vasopressors?
Although generally preferred, central venous catheters carry risks such as procedural complications, infection, and thrombosis. Clinicians must assess, case by case, whether a peripheral intravenous catheter can be used.
Functional dyspepsia: How to manage the burn and the bloatThe authors discuss how to diagnose and treat the 2 subtypes of functional dyspepsia: epigastric pain syndrome (burning and pain) and postprandial distress syndrome (bloating and satiety).
- Acquired reactive perforating collagenosis in a patient with diabetes
A 47-year-old woman presented with a 2-month history of pruritic eruptions on the left ankle and a complaint of thirst and polyuria for the past year.
- Glucocorticoid-induced adrenal insufficiency and glucocorticoid withdrawal syndrome: Two sides of the same coin
This review highlights the differences between primary adrenal insufficiency, secondary adrenal insufficiency, including glucocorticoid-induced adrenal insufficiency, and glucocorticoid withdrawal syndrome.
- When should I give corticosteroids to my patient with Pneumocystis pneumonia?
Patients with HIV infection who are hypoxemic should receive corticosteroids. Evidence for patients without HIV infection is limited.
- Corticosteroids: Giving and taking away
Two articles this month highlight opposite ends of the treatment spectrum, one on introducing adjunctive corticosteroids when treating Pneumocystis pneumonia, and the other on syndromes associated with glucocorticoid withdrawal.
- Management of lower-extremity venous thromboembolism: An updated review
A review of the 2021 updated guidelines of the American College of Chest Physicians including risk factors, supportive management, choice of anticoagulation therapy, and treatment considerations.
- Nonhormone therapies for vasomotor symptom management
The authors provide an up-to-date overview of evidence-based nonhormone therapies available for management of vasomotor symptoms.
- Microscopic colitis: What is it, and what are the treatment options?
Budesonide, first-line therapy for this inflammatory disorder characterized by chronic diarrhea, improves symptoms and quality of life.
